Skip to main content
logo
Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9800
+0.0300 (3.16%)
Jul 10, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Scientific research services and CRO
59.57M44.66M26.39M7.94M-
Scientific research services and CRO Growth
33.40%69.20%232.53%--
Oncology Testing
44.80M21.72M32.06M17.87M8.62M
Oncology Testing Growth
106.22%-32.25%79.41%107.45%13.40%
Routine Testing
41.28M42.39M57.47M57.44M67.67M
Routine Testing Growth
-2.64%-26.24%0.06%-15.12%0.20%
Maternity-Related Testing
50.24M53.88M55.42M49.96M52.25M
Maternity-Related Testing Growth
-6.75%-2.77%10.92%-4.38%0.25%
Neurology Testing
95.05M95.35M96.60M95.35M89.85M
Neurology Testing Growth
-0.31%-1.30%1.31%6.12%18.16%
Others
3.12M277.00K13.29M5.14M19.46M
Others Growth
1024.55%-97.91%158.66%-73.60%36.10%
Hematology Testing
563.13M585.11M590.31M525.80M535.27M
Hematology Testing Growth
-3.76%-0.88%12.27%-1.77%14.05%
Infectious Diseases
35.44M39.43M49.00M47.69M51.97M
Infectious Diseases Growth
-10.12%-19.53%2.74%-8.23%3.03%
Genetic Disease and Rare Diseases
40.94M44.75M46.72M42.78M43.50M
Genetic Disease and Rare Diseases Growth
-8.50%-4.21%9.20%-1.65%20.23%
COVID-19 Related Testing
---536.63M62.10M
COVID-19 Related Testing Growth
---764.07%-47.30%
Total
933.57M927.57M967.26M1.39B930.67M
Total Growth
0.65%-4.10%-30.24%48.99%4.41%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Mainland China
933.57M927.57M967.26M1.39B930.67M
Mainland China Growth
0.65%-4.10%-30.24%48.99%4.41%
Total
933.57M927.57M967.26M1.39B930.67M
Total Growth
0.65%-4.10%-30.24%48.99%4.41%